These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9922142

  • 1. Crystal structure of the complex between VEGF and a receptor-blocking peptide.
    Wiesmann C, Christinger HW, Cochran AG, Cunningham BC, Fairbrother WJ, Keenan CJ, Meng G, de Vos AM.
    Biochemistry; 1998 Dec 22; 37(51):17765-72. PubMed ID: 9922142
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
    Starovasnik MA, Christinger HW, Wiesmann C, Champe MA, de Vos AM, Skelton NJ.
    J Mol Biol; 1999 Oct 29; 293(3):531-44. PubMed ID: 10543948
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA, Christinger HW, Keyt BA, de Vos AM.
    Structure; 1997 Oct 15; 5(10):1325-38. PubMed ID: 9351807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
    Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM.
    Cell; 1997 Nov 28; 91(5):695-704. PubMed ID: 9393862
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
    Piossek C, Schneider-Mergener J, Schirner M, Vakalopoulou E, Germeroth L, Thierauch KH.
    J Biol Chem; 1999 Feb 26; 274(9):5612-9. PubMed ID: 10026178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT, Yu Y, Whitney RG, Sato JD.
    Biochem Biophys Res Commun; 1999 Sep 07; 262(3):731-8. PubMed ID: 10471394
    [Abstract] [Full Text] [Related]

  • 11. Crystallization of the receptor binding domain of vascular endothelial growth factor.
    Christinger HW, Muller YA, Berleau LT, Keyt BA, Cunningham BC, Ferrara N, de Vos AM.
    Proteins; 1996 Nov 07; 26(3):353-7. PubMed ID: 8953654
    [Abstract] [Full Text] [Related]

  • 12. Computer modelling of the receptor-binding domains of VEGF and PIGF.
    Walsh TP, Grant GH.
    Protein Eng; 1997 Apr 07; 10(4):389-98. PubMed ID: 9194163
    [Abstract] [Full Text] [Related]

  • 13. 1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor.
    Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA.
    Protein Sci; 1997 Oct 07; 6(10):2250-60. PubMed ID: 9336848
    [Abstract] [Full Text] [Related]

  • 14. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation.
    Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F.
    J Cell Sci; 2000 Jan 05; 113 ( Pt 1)():59-69. PubMed ID: 10591625
    [Abstract] [Full Text] [Related]

  • 16. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
    Siemeister G, Schirner M, Reusch P, Barleon B, Marmé D, Martiny-Baron G.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4625-9. PubMed ID: 9539788
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.